We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+14.12%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.95B
AUM Growth
+$1.22B
Cap. Flow
+$1.04B
Cap. Flow %
53.23%
Top 10 Hldgs %
36.2%
Holding
567
New
178
Increased
136
Reduced
71
Closed
115

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$89.8M
2
TSLA icon
Tesla
TSLA
+$78.2M
3
ADI icon
Analog Devices
ADI
+$64.3M
4
GM icon
General Motors
GM
+$50.9M
5
ADBE icon
Adobe
ADBE
+$45.4M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$16.1M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$15.2M
3
PBR icon
Petrobras
PBR
+$10.6M
4
MELI icon
Mercado Libre
MELI
+$9.89M
5
TTWO icon
Take-Two Interactive
TTWO
+$9.83M

Sector Composition

Rank Sector Weight
1 Technology 35.61%
2 Consumer Discretionary 16.88%
3 Financials 12.52%
4 Communication Services 8.3%
5 Healthcare 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWL icon
451
American Well
AMWL
$231M
$59.6K ﹤0.01%
2,001
RBBN icon
452
Ribbon Communications
RBBN
$367M
$44K ﹤0.01%
15,169
A icon
453
Agilent Technologies
A
$42B
-13,737
Closed -$1.54M
AAP icon
454
Advance Auto Parts
AAP
$3.36B
-21,874
Closed -$1.22M
AAXJ icon
455
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.74B
-71,828
Closed -$4.56M
AGEN
456
Agenus
AGEN
$291M
-19,512
Closed -$441K
AL
457
DELISTED
Air Lease Corp
AL
-21,256
Closed -$838K
ALGN icon
458
Align Technology
ALGN
$12.5B
-1,253
Closed -$383K
ALTO icon
459
Alto Ingredients
ALTO
$328M
-56,332
Closed -$249K
AMLP icon
460
Alerian MLP ETF
AMLP
$13.3B
-13,245
Closed -$559K
ANIP icon
461
ANI Pharmaceuticals
ANIP
$1.72B
-3,990
Closed -$232K
APH icon
462
Amphenol
APH
$207B
-18,384
Closed -$772K
ARE icon
463
Alexandria Real Estate Equities
ARE
$8.32B
-13,405
Closed -$1.34M
ARLO icon
464
Arlo Technologies
ARLO
$1.6B
-19,671
Closed -$203K
BA icon
465
Boeing
BA
$184B
-20,000
Closed -$3.83M
BBIO icon
466
BridgeBio Pharma
BBIO
$16.6B
-7,843
Closed -$207K
BBW icon
467
Build-A-Bear
BBW
$467M
-8,013
Closed -$236K
BLUE
468
DELISTED
bluebird bio
BLUE
-7,619
Closed -$463K
CAR icon
469
Avis
CAR
$4.9B
-1,511
Closed -$272K
CCJ icon
470
CALL
Cameco
CCJ
$42.4B
-100,000
Closed -$3.96M
CHRS icon
471
Coherus Oncology
CHRS
$192M
-89,473
Closed -$335K
CL icon
472
Colgate-Palmolive
CL
$74.3B
-3,076
Closed -$219K
CMA
473
DELISTED
Comerica
CMA
-15,485
Closed -$643K
CMCSA icon
474
Comcast
CMCSA
$89.4B
-150,000
Closed -$6.65M
CNX icon
475
CNX Resources
CNX
$5.32B
-111,283
Closed -$2.51M

Similar funds

Caxton Associates (New York)'s Q4 2023 Portfolio in Review

As of Q4 2023, Caxton Associates (New York) held 567 positions worth $1.95B, up 168% from $727M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Caxton Associates (New York) deployed $1.04B of net new capital in Q4 2023, opening 178 new positions and adding to 136 existing holdings. Its largest new stake was Analog Devices: 360,000 shares worth $71.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was DocuSign, an estimated $8.73M trimmed.

  • Caxton Associates (New York)'s largest Q4 2023 buy was Analog Devices: 360,000 shares worth $71.5M.
  • Caxton Associates (New York) added most to Microsoft in Q4 2023, an estimated $89.8M increase.
  • Caxton Associates (New York)'s biggest Q4 2023 reduction was DocuSign, cutting an estimated $8.73M.
  • Caxton Associates (New York) fully exited Netflix in Q4 2023, selling an estimated $16.1M.
  • Caxton Associates (New York)'s ten largest holdings make up 36% of its $1.95B portfolio in Q4 2023.
  • Caxton Associates (New York) opened 178 new positions and closed 115 in Q4 2023.
  • Caxton Associates (New York)'s portfolio value rose 168% quarter-over-quarter to $1.95B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.